TC-002 is the first of four proprietary glaucoma drugs in the TearClear near term pipeline CHICAGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- TearClear, an ophthalmic pharmaceutical company that transforms ...
Latanoprost is a generic prescription medication. The Food and Drug Administration (FDA) has approved it to treat increased pressure in the eyes. The drug is for use in adults who have either ...
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ...
UPPSALA, Sweden — Latanoprost (Xalatan, Pharmacia Corp.) reduced diurnal intraocular pressure (IOP) significantly more than timolol, according to a meta-analysis of eight global randomized trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results